CAPR R&D Expense Growth
Capricor Therapeutics Inc · R&D Expense Growth
CAPR R&D Expense Growth
Latest reported69.02%period ending
CAPR FY R&D Growth (YoY) (0.00% → 69.02%)
Latest values, visible window
High-resolution chart · PNG
CAPR r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 69.0154% | |
| 37.0954% | |
| 67.063% | |
| 60.761% | |
| 60.4711% | |
| 64.4753% | |
| -57.3895% | |
| 12.0843% | |
| -32.8887% | |
| 16.6097% | |
| 76.6662% | |
| 49.8364% | |
| 407.5195% | |
| -75.2478% | |
| 1.3722% | |
| -8.6411% | |
| -52.8698% | |
| 84.9727% | |
| 89.7738% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |